IIS: HL7 Standard Code Set
Mapping CVX to Vaccine Groups

A variety of vaccines can be used to vaccinate against a specific disease in fulfillment of the Advisory Committee on Immunization Practices (ACIP) schedule. Multiple individual vaccines that can be used to vaccinate against a disease are grouped into a Vaccine Group (sometimes known as vaccine family), and in many cases these groups represent vaccines that vaccinate against a single disease. In a few cases they represent vaccines that vaccinate against more than one disease, but are grouped together because clinicians have thought of them as a unit.

CVX codes are codes that indicate the product used in a vaccination. MVX codes are codes that indicate the manufacturer of a vaccine. These codes are maintained by the Centers for Disease Control and Prevention, Immunization Information System Support Branch (IISSB) for use in HL7 data transmission.

The goal of the table is to support mapping of CVX to vaccine groups.

Note: The column formerly known as “Uncertain Formulation CVX” has been changed to “CVX for Vaccine Group”. This is the code to use for identifying the vaccine group in HL7 messages for forecasting next dose due and for other cases where vaccine group needs to be identified.

Questions regarding this table should be directed to the IIS Technical Assistance Team(or use mailing address).

Sort Table by Column: Simply click on the column heading to sort the table accordingly.

Short DescriptionCVX CodeVaccine statusVaccine Group
Name
CVX for
Vaccine Group
DTP 01 InactiveDTAP107
OPV 02 InactivePOLIO89
MMR 03 ActiveMMR03
M/R 04 InactiveMMR03
measles 05 InactiveMMR03
rubella 06 InactiveMMR03
mumps 07 InactiveMMR03
Hep B, adolescent or pediatric 08 ActiveHepB45
Td (adult), 2 Lf tetanus toxoid, preservative free, adsorbed 09 ActiveTd139
IPV 10 ActivePOLIO89
pneumococcal conjugate PCV 7 100 InactivePneumoPCV152
typhoid, ViCPs 101 ActiveTYPHOID91
DTP-Hib-Hep B 102 Non-USHIB17
DTP-Hib-Hep B 102 Non-USHepB45
DTP-Hib-Hep B 102 Non-USDTAP107
meningococcal C conjugate 103 InactiveMENING108
Hep A-Hep B 104 ActiveHepB45
Hep A-Hep B 104 ActiveHepA85
vaccinia (smallpox) diluted 105 InactiveOrthopoxvirus75
DTaP, 5 pertussis antigens 106 ActiveDTAP107
DTaP, unspecified formulation 107 InactiveDTAP107
meningococcal ACWY, unspecified formulation 108 InactiveMENING108
pneumococcal, unspecified formulation 109 InactivePneumoPCV152
pneumococcal, unspecified formulation 109 InactivePneumoPPV33
DTaP-Hep B-IPV 110 ActiveDTAP107
DTaP-Hep B-IPV 110 ActiveHepB45
DTaP-Hep B-IPV 110 ActivePOLIO89
influenza, live, intranasal 111 InactiveFLU88
Td (adult), 5 Lf tetanus toxoid, preservative free, adsorbed 113 ActiveTd139
meningococcal MCV4P 114 ActiveMENING108
Tdap 115 ActiveTDAP115
rotavirus, pentavalent 116 ActiveROTAVIRUS122
HPV, bivalent 118 InactiveHPV137
rotavirus, monovalent 119 ActiveROTAVIRUS122
DTaP-Hib-IPV 120 ActivePOLIO89
DTaP-Hib-IPV 120 ActiveDTAP107
DTaP-Hib-IPV 120 ActiveHIB17
zoster live 121 ActiveZOSTER188
rotavirus, unspecified formulation 122 InactiveROTAVIRUS122
influenza, H5N1-1203 123 InactiveH5N1 flu123
Novel Influenza-H1N1-09, nasal 125 InactiveH1N1 flu128
Novel influenza-H1N1-09, preservative-free 126 InactiveH1N1 flu128
Novel influenza-H1N1-09 127 InactiveH1N1 flu128
Novel Influenza-H1N1-09, all formulations 128 InactiveH1N1 flu128
Japanese Encephalitis, unspecified formulation 129 InactiveJapanese encephalitis129
DTaP-IPV 130 ActivePOLIO89
DTaP-IPV 130 ActiveDTAP107
DTaP-IPV-HIB-HEP B, historical 132 InactiveDTAP107
DTaP-IPV-HIB-HEP B, historical 132 InactiveHIB17
DTaP-IPV-HIB-HEP B, historical 132 InactivePOLIO89
DTaP-IPV-HIB-HEP B, historical 132 InactiveHepB45
Pneumococcal conjugate PCV 13 133 ActivePneumoPCV152
Japanese Encephalitis IM 134 ActiveJapanese encephalitis129
Influenza, high dose seasonal 135 ActiveFLU88
Meningococcal MCV4O 136 ActiveMENING108
HPV, unspecified formulation 137 InactiveHPV137
Td (adult) 138 InactiveTd139
Td(adult) unspecified formulation 139 InactiveTd139
Influenza, seasonal, injectable, preservative free 140 InactiveFLU88
Influenza, seasonal, injectable 141 ActiveFLU88
Adenovirus types 4 and 7 143 ActiveADENO82
influenza, seasonal, intradermal, preservative free 144 InactiveFLU88
DTaP,IPV,Hib,HepB 146 ActivePOLIO89
DTaP,IPV,Hib,HepB 146 ActiveDTAP107
DTaP,IPV,Hib,HepB 146 ActiveHIB17
DTaP,IPV,Hib,HepB 146 ActiveHepB45
meningococcal MCV4, unspecified formulation 147 InactiveMENING108
Meningococcal C/Y-HIB PRP 148 InactiveMENING108
Meningococcal C/Y-HIB PRP 148 InactiveHIB17
influenza, live, intranasal, quadrivalent 149 ActiveFLU88
influenza, split (incl. purified surface antigen) 15 InactiveFLU88
influenza, injectable, quadrivalent, preservative free 150 ActiveFLU88
influenza nasal, unspecified formulation 151 InactiveFLU88
Pneumococcal Conjugate, unspecified formulation 152 InactivePneumoPCV152
Influenza, injectable, MDCK, preservative free 153 InactiveFLU88
influenza, recombinant, injectable, preservative free 155 ActiveFLU88
influenza, injectable, quadrivalent 158 ActiveFLU88
influenza, whole 16 InactiveFLU88
Influenza A monovalent (H5N1), ADJUVANTED-2013 160 ActiveH5N1 flu123
Influenza, injectable,quadrivalent, preservative free, pediatric 161 ActiveFLU88
meningococcal B, recombinant 162 ActiveMeningB164
meningococcal B, OMV 163 ActiveMeningB164
meningococcal B, unspecified 164 InactiveMeningB164
HPV9 165 ActiveHPV137
influenza, intradermal, quadrivalent, preservative free 166 InactiveFLU88
influenza, trivalent, adjuvanted 168 ActiveFLU88
Hib, unspecified formulation 17 InactiveHIB17
DTAP/IPV/HIB - non-US 170 Non-USPOLIO89
DTAP/IPV/HIB - non-US 170 Non-USHIB17
DTAP/IPV/HIB - non-US 170 Non-USDTAP107
Influenza, injectable, MDCK, preservative free, quadrivalent 171 ActiveFLU88
cholera, WC-rBS 172 Non-UScholera26
cholera, BivWC 173 Non-UScholera26
cholera, live attenuated 174 Activecholera26
Rabies - IM Diploid cell culture 175 ActiveRABIES90
Rabies - IM fibroblast culture 176 ActiveRABIES90
PCV10 177 Non-USPneumoPCV152
rabies, intramuscular injection 18 InactiveRABIES90
Yellow fever vaccine - alt 183 ActiveYELLOWFEVER184
Yellow fever, unspecified formulation 184 InactiveYELLOWFEVER184
influenza, recombinant, quadrivalent,injectable, preservative free 185 ActiveFLU88
Influenza, injectable, MDCK, quadrivalent, preservative 186 ActiveFLU88
zoster recombinant 187 ActiveZOSTER188
zoster, unspecified formulation 188 InactiveZOSTER188
HepB-CpG 189 ActiveHepB45
BCG 19 ActiveBCG19
Hep A-Hep B, pediatric/adolescent 193 Non-USHepB45
Hep A-Hep B, pediatric/adolescent 193 Non-USHepA85
Influenza, Southern Hemisphere 194 InactiveFLU88
DT, IPV adsorbed 195 Non-USTd139
DT, IPV adsorbed 195 Non-USPOLIO89
Td, adsorbed, preservative free, adult use, Lf unspecified 196 ActiveTd139
influenza, high-dose, quadrivalent 197 ActiveFLU88
DTaP 20 ActiveDTAP107
influenza, Southern Hemisphere, pediatric, preservative free 200 ActiveFLU88
influenza, Southern Hemisphere, preservative free 201 ActiveFLU88
influenza, Southern Hemisphere, quadrivalent, with preservative 202 ActiveFLU88
meningococcal conjugate quadrivalent, MenACWY-TT (MCV4) 203 ActiveMENING108
Ebola Zaire vaccine, live, recombinant, 1mL dose 204 ActiveEbola214
Influenza vaccine, quadrivalent, adjuvanted 205 ActiveFLU88
Vaccinia, smallpox Mpox vaccine live, PF, SQ or ID injection 206 ActiveOrthopoxvirus75
COVID-19, mRNA, LNP-S, PF, 100 mcg/0.5mL dose or 50 mcg/0.25mL dose 207 InactiveCOVID-19213
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose 208 InactiveCOVID-19213
varicella 21 ActiveVARICELLA21
COVID-19 vaccine, vector-nr, rS-ChAdOx1, PF, 0.5 mL 210 Non-USCOVID-19213
COVID-19, subunit, rS-nanoparticle+Matrix-M1 Adjuvant, PF, 0.5 mL 211 InactiveCOVID-19213
COVID-19 vaccine, vector-nr, rS-Ad26, PF, 0.5 mL 212 InactiveCOVID-19213
SARS-COV-2 (COVID-19) vaccine, UNSPECIFIED 213 InactiveCOVID-19213
Ebola, unspecified 214 InactiveEbola214
Pneumococcal conjugate PCV15, polysaccharide CRM197 conjugate, adjuvant, PF 215 ActivePneumoPCV152
Pneumococcal conjugate PCV20, polysaccharide CRM197 conjugate, adjuvant, PF 216 ActivePneumoPCV152
COVID-19, mRNA, LNP-S, PF, 30 mcg/0.3 mL dose, tris-sucrose 217 InactiveCOVID-19213
COVID-19, mRNA, LNP-S, PF, 10 mcg/0.2 mL dose, tris-sucrose 218 InactiveCOVID-19213
COVID-19, mRNA, LNP-S, PF, 3 mcg/0.2 mL dose, tris-sucrose 219 InactiveCOVID-19213
DTP-Hib 22 InactiveDTAP107
DTP-Hib 22 InactiveHIB17
HepB recombinant, 3-antigen, Al(OH)3 220 ActiveHepB45
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL dose 221 InactiveCOVID-19213
Tick-borne encephalitis, unspecified 222 InactiveTick-borne encephalitis222
Tick-borne encephalitis, inactivated, PF, 0.25mL 223 ActiveTick-borne encephalitis222
Tick-borne encephalitis, inactivated, PF, 0.5mL 224 ActiveTick-borne encephalitis222
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 5mcg/0.5mL 225 Never ActiveCOVID-19213
COVID-19, D614, recomb, preS dTM, AS03 adjuvant add, PF, 10mcg/0.5mL 226 Never ActiveCOVID-19213
COVID-19, mRNA, LNP-S, PF, pediatric 50 mcg/0.5 mL dose 227 InactiveCOVID-19213
COVID-19, mRNA, LNP-S, PF, pediatric 25 mcg/0.25 mL dose 228 InactiveCOVID-19213
COVID-19, mRNA, LNP-S, bivalent, PF, 50 mcg/0.5 mL or 25mcg/0.25 mL dose 229 InactiveCOVID-19213
plague 23 InactivePlague23
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL 230 InactiveCOVID-19213
influenza, Southern Hemisphere, high-dose, quadrivalent 231 ActiveFLU88
Anthrax, pre-exposure prophylaxis, post-exposure prophylaxis 24 ActiveANTHRAX24
typhoid, oral 25 ActiveTYPHOID91
cholera, unspecified formulation 26 Inactivecholera26
DT (pediatric) 28 ActiveDTAP107
COVID-19, mRNA, LNP-S, bivalent, PF, 30 mcg/0.3 mL dose 300 InactiveCOVID-19213
COVID-19, mRNA, LNP-S, bivalent, PF, 10 mcg/0.2 mL dose 301 InactiveCOVID-19213
COVID-19, mRNA, LNP-S, bivalent, PF, 3 mcg/0.2 mL dose 302 InactiveCOVID-19213
RSV, recombinant, protein subunit RSVpreF, adjuvant reconstituted, 0.5 mL, PF 303 ActiveRSV304
Respiratory syncytial virus (RSV), unspecified 304 InactiveRSV304
RSV, bivalent, protein subunit RSVpreF, diluent reconstituted, 0.5 mL, PF 305 ActiveRSV304
RSV, mAb, nirsevimab-alip, 0.5 mL, neonate to 24 months 306 ActiveRSV304
RSV, mAb, nirsevimab-alip, 1 mL, neonate to 24 months 307 ActiveRSV304
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 3 mcg/0.3 mL 308 ActiveCOVID-19213
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 30 mcg/0.3 mL 309 ActiveCOVID-19213
Hep A, pediatric, unspecified formulation 31 InactiveHepA85
COVID-19, mRNA, LNP-S, PF, tris-sucrose, 10 mcg/0.3 mL 310 ActiveCOVID-19213
COVID-19, mRNA, LNP-S, PF, 25 mcg/0.25 mL 311 ActiveCOVID-19213
COVID-19, mRNA, LNP-S, PF, 50 mcg/0.5 mL 312 ActiveCOVID-19213
COVID-19, subunit, rS-nanoparticle, adjuvanted, PF, 5 mcg/0.5 mL 313 ActiveCOVID-19213
Respiratory syncytial virus (RSV) vaccine, unspecified 314 InactiveRSV304
Respiratory syncytial virus (RSV) MAB, unspecified 315 InactiveRSV304
Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF 316 ActiveMENING108
Meningococcal polysaccharide (MenACWY-TT conjugate), (MenB), PF 316 ActiveMeningB164
Chikungunya live attenuated vaccine, 0.5 mL, PF 317 ActiveChikungunya317
Anthrax, post-exposure prophylaxis 318 ActiveANTHRAX24
meningococcal MPSV4 32 InactiveMENING108
pneumococcal polysaccharide PPV23 33 ActivePneumoPPV33
tetanus toxoid, adsorbed 35 InactiveTd139
yellow fever 37 ActiveYELLOWFEVER184
rubella/mumps 38 InactiveMMR03
Japanese encephalitis SC 39 InactiveJapanese encephalitis129
rabies, intradermal injection 40 InactiveRABIES90
typhoid, parenteral 41 InactiveTYPHOID91
Hep B, adolescent/high risk infant 42 InactiveHepB45
Hep B, adult 43 ActiveHepB45
Hep B, dialysis 44 ActiveHepB45
Hep B, unspecified formulation 45 InactiveHepB45
Hib (PRP-D) 46 InactiveHIB17
Hib (HbOC) 47 InactiveHIB17
Hib (PRP-T) 48 ActiveHIB17
Hib (PRP-OMP) 49 ActiveHIB17
DTaP-Hib 50 InactiveHIB17
DTaP-Hib 50 InactiveDTAP107
COVID-19 Non-US Vaccine, Product Unknown 500 Non-USCOVID-19213
COVID-19 IV Non-US Vaccine (QAZCOVID-IN) 501 Non-USCOVID-19213
COVID-19 IV Non-US Vaccine (COVAXIN) 502 Non-USCOVID-19213
COVID-19 LAV Non-US Vaccine (COVIVAC) 503 Non-USCOVID-19213
COVID-19 VVnr Non-US Vaccine (Sputnik Light) 504 Non-USCOVID-19213
COVID-19 VVnr Non-US Vaccine (Sputnik V) 505 Non-USCOVID-19213
COVID-19 VVnr Non-US Vaccine (CanSino Biological Inc./Beijing Institute of Biotechnology 506 Non-USCOVID-19213
COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom Biopharm + Inst of Micro, Chinese Acad of Sciences) 507 Non-USCOVID-19213
COVID-19 PS Non-US Vaccine (Jiangsu Province Centers for Disease Control and Prevention) 508 Non-USCOVID-19213
COVID-19 PS Non-US Vaccine (EpiVacCorona) 509 Non-USCOVID-19213
Hib-Hep B 51 InactiveHIB17
Hib-Hep B 51 InactiveHepB45
COVID-19 IV Non-US Vaccine (BIBP, Sinopharm) 510 Non-USCOVID-19213
COVID-19 IV Non-US Vaccine (CoronaVac, Sinovac) 511 Non-USCOVID-19213
SARS-COV-2 COVID-19 VLP Non-US Vaccine (Medicago, Covifenz) 512 Non-USCOVID-19213
SARS-COV-2 COVID-19 PS Non-US Vaccine (Anhui Zhifei Longcom, Zifivax) 513 Non-USCOVID-19213
SARS-COV-2 COVID-19 DNA Non-US Vaccine (Zydus Cadila, ZyCoV-D) 514 Non-USCOVID-19213
SARS-COV-2 COVID-19 PS Non-US Vaccine (Medigen, MVC-COV1901) 515 Non-USCOVID-19213
COV-2 COVID-19 Inactivated Non-US Vaccine Product (Minhai Biotechnology Co, KCONVAC) 516 Non-USCOVID-19213
SARS-COV-2 COVID-19 PS Non-US Vaccine (Biological E Limited, Corbevax) 517 Non-USCOVID-19213
COVID-19 Inactivated, Non-US Vaccine (VLA2001, Valneva) 518 Non-USCOVID-19213
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine (Spikevax Bivalent), Moderna 519 Non-USCOVID-19213
Hep A, adult 52 ActiveHepA85
COVID-19 mRNA, bivalent, original/Omicron BA.1, Non-US Vaccine Product, Pfizer-BioNTech 520 Non-USCOVID-19213
COVID-19 SP, protein-based, adjuvanted (VidPrevtyn Beta), Sanofi-GSK 521 Non-USCOVID-19213
typhoid, parenteral, AKD (U.S. military) 53 InactiveTYPHOID91
adenovirus, type 4 54 InactiveADENO82
adenovirus, type 7 55 InactiveADENO82
dengue fever tetravalent 56 ActiveDENGUE56
HPV, quadrivalent 62 ActiveHPV137
Lyme disease 66 InactiveLyme disease66
rotavirus, tetravalent 74 InactiveROTAVIRUS122
vaccinia (smallpox) 75 ActiveOrthopoxvirus75
Tick-borne encephalitis vaccine (non-US) 77 Non-USTick-borne encephalitis222
VEE, live 80 InactiveVEE92
VEE, inactivated 81 InactiveVEE92
adenovirus, unspecified formulation 82 InactiveADENO82
Hep A, ped/adol, 2 dose 83 ActiveHepA85
Hep A, ped/adol, 3 dose 84 InactiveHepA85
Hep A, unspecified formulation 85 InactiveHepA85
influenza, unspecified formulation 88 InactiveFLU88
polio, unspecified formulation 89 InactivePOLIO89
rabies, unspecified formulation 90 InactiveRABIES90
typhoid, unspecified formulation 91 InactiveTYPHOID91
VEE, unspecified formulation 92 InactiveVEE92
MMRV 94 ActiveMMR03
MMRV 94 ActiveVARICELLA21

 Top of Page



For further information on HL7 immunization data exchange and the CVX code set, contact the IIS Technical Assistance Team at:

Address:
CDC, National Centers for Immunization and Respiratory Diseases
Immunization Information System Support Branch - Informatics
1600 Clifton Road
Mailstop: E-62
Atlanta, GA 30333
Email:
iisinfo@cdc.gov (note change)

Page last reviewed: January 31, 2024